Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
Monika Lejman(Medical University of Lublin), Maciej Dobosz(Medical University of Lublin)
Cited by 74
Related Papers
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
|International Journal of Molecular Sciences|2021|81
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
|International Journal of Molecular Sciences|2022|58
Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
|Biomedicines|2023|58
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
|International Journal of Molecular Sciences|2021|35